Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial

Background: Quercetin, a natural polyphenol with demonstrated broad-spectrum antiviral, anti-inflammatory, and antioxidant properties, has been proposed as an adjuvant for early-stage coronavirus disease 2019 (COVID-19) infection. Objective: To explore the possible therapeutic effect of quercetin in...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Pierro, Francesco, Khan, Amjad, Iqtadar, Somia, Mumtaz, Sami Ullah, Chaudhry, Muhammad Nabeel Akbar, Bertuccioli, Alexander, Derosa, Giuseppe, Maffioli, Pamela, Togni, Stefano, Riva, Antonella, Allegrini, Pietro, Recchia, Martino, Zerbinati, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880293/
https://www.ncbi.nlm.nih.gov/pubmed/36712674
http://dx.doi.org/10.3389/fphar.2022.1096853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880293/
https://www.ncbi.nlm.nih.gov/pubmed/36712674
http://dx.doi.org/10.3389/fphar.2022.1096853

Ejemplares similares